Wenyuan Mai

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Huafeng Wang, Liping Mao, Min Yang et al. · The Lancet Haematology · 2022 · 97 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

Hongyan Tong, Yanling Ren, Hui Liu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 82 citations

Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy

Yinjun Lou, Yafang Ma, Shanshan Suo et al. · Leukemia Research · 2015 · 45 citations

Prognostic Factors, Hematological Malignancy, Medicine +8

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Yinjun Lou, Yafang Ma, Jianai Sun et al. · Annals of Hematology · 2015 · 43 citations

Hematological Malignancy, Oncology, Medicine +9

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience

Wenjuan Yu, Liping Mao, Jiejing Qian et al. · Annals of Hematology · 2013 · 36 citations

Hematological Malignancy, Medicinal Chemistry, Medicine +7